GlassScriptPhysician profile
Daniel T Fang
NPI 1033170634
$22,078.90
in general payments reported to CMS, 2019-2025
10 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,815 · 2020: $11K · 2021: $6,578 · 2022: $1,410 · 2023: $491 · 2024: $74.67 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,530.08 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $850.91 | 2019-2025 | Harmonic, Megadyne, Echelon Flex |
| Medtronic, INC. | $267.53 | 2023-2025 | Signia |
| Medtronic Vascular, INC. | $131.16 | 2020 | |
| Davol INC. | $126.60 | 2021 | |
| Teleflex LLC | $90.02 | 2025 | Titan Sgs Bailout Chuck |
| Baxter Healthcare | $26.68 | 2023 | Tisseel |
| Abbott Laboratories | $23.82 | 2023 | Proclaim |
| Boston Scientific Corporation | $17.59 | 2022 | |
| Tei Biosciences INC | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.